Longevity Aspen Neuro lands $115m to advance Parkinson’s cell therapyBy adminNovember 24, 20250 Company’s Parkinson’s therapy is designed to restore dopamine function by rebuilding neural networks using a patient’s own stem cells. US…
Longevity Klotho Neuro moves to acquire Turn Bio assetsBy adminOctober 2, 20250 Longevity biotech seeks to broaden its therapeutic capabilities with cellular reprogramming and delivery technologies. Longevity-focused biotech Klotho Neurosciences revealed it…
